Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment

NCT03489473 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT03489473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03489473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2020
Completion date
December 1, 2021
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer